As a global ophthalmic technology company, we take pride at Mynosys in providing surgeons across the world with innovative solutions that promote procedural excellence.

Currently, we’re focusing on our unprecedented ZEPTO® Precision Cataract Surgery platform, as it continues to advance the safety and precision of cataract surgery outcomes. By providing a safe, predictable, effective new way to automate the anterior capsulotomy, the ZEPTO® platform helps surgeons reduce risk, increase edge strength, and improve precision in cataract procedures.

Moving forward, we’ll leverage this micro-surgical technology to create a suite of products for ophthalmic capsular management. Our relentless commitment to developing solutions of the highest quality and technological sophistication is uncompromising – is our dedication to assisting physicians in delivering the best care to patients.

ZEPTO by Mynosys Cellular Devices Inc.



29 Jul Precision pulse capsulotomy in challenging cataract surgery cases A new case study using the Zepto Precision Cataract Surgery system ... read more ›
10 Jul Cataract Surgery with Zepto and MIGS – EyeTube Video In this EyeTube video, Georges Durr, MD, FRCSC, and Iqbal (Ike) K. ... read more ›
30 May Dr. Vance Thompson Helio Interview at OSN Italy 2019 At the OSN Italy meeting last week, Dr. Vance Thompson gave the ... read more ›